VAXIPET P INJECTION FREEZE-DRIED VACCINE (PARVOUIRAS ENTARITIDIS CANIS)

Indications

• Pain management
• Post-surgical recovery
• Infections
• Chronic inflammatory diseases
• Neurological disorders

Dosage

Children: Paediatric dosing in dogs is also highly variable and should be determined by a veterinarian based on the specific medication and the puppy's age, weight, and overall health.

Adults: Dosage for adult dogs varies significantly based on the specific medication and condition being treated. It is essential to refer to a veterinary professional for accurate dosing.

Mechanism of action

The pharmacological actions in canines often depend on the specific medication being used. For instance, non-steroidal anti-inflammatory drugs (NSAIDs) used in dogs, such as carprofen, work by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thus reducing the formation of prostaglandins that mediate inflammation and pain. Antibiotics may exert their effects by inhibiting bacterial cell wall synthesis or protein synthesis, ultimately leading to bacterial cell death or growth inhibition.

Pharmacodynamics

The pharmacodynamics of drugs used in canines typically involve their interaction with biological systems to produce therapeutic effects. For analgesics, the primary effect is pain relief, while anti-inflammatories reduce swelling and inflammation. The efficacy of these medications can vary based on the individual dog's health status, age, and breed, necessitating careful monitoring and dose adjustments.

Pharmacokinetics

Pharmacokinetics in dogs can vary significantly based on the drug's formulation and the dog's metabolic rate. Generally, after administration, drugs are absorbed into the bloodstream, distributed to tissues, metabolized primarily in the liver, and excreted through the kidneys. Factors such as age, size, health conditions, and concurrent medications can influence these processes, impacting the drug's effectiveness and safety.

Pregnancy

Safety during pregnancy has not been established. Use should be avoided unless the potential benefits outweigh the risks.

Breast-feeding

Safety during breastfeeding has not been established. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

Dosage

Children: Refer to established guidelines or clinical protocols for dosing information.

Adults: Refer to established guidelines or clinical protocols for dosing information.

Pregnancy

The safety of entaritidis during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether entaritidis is excreted in human milk. Caution should be exercised when administering to a nursing mother.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Viral infections
• Specific viral pathogens (as indicated by local treatment guidelines)

Dosage

Children: Refer to local clinical guidelines for specific dosing recommendations.

Adults: Refer to local clinical guidelines for specific dosing recommendations.

Mechanism of action

Parvouiras functions by targeting viral proteins essential for the replication and assembly of viral particles, thereby inhibiting the virus's ability to proliferate. It may interfere with the viral life cycle at various stages, including entry into host cells and the release of new virions.

Pharmacodynamics

The pharmacodynamics of parvouiras involve its interaction with viral enzymes and proteins, leading to a decrease in viral load and an improvement in clinical symptoms associated with viral infections. Its effectiveness can vary depending on the specific virus being targeted and the presence of resistance mechanisms.

Pharmacokinetics

Parvouiras is absorbed after oral administration, with peak plasma concentrations occurring within a few hours. It is metabolized in the liver, and its elimination half-life allows for once-daily dosing in many cases. The drug is excreted primarily through the urine, and renal function may influence its clearance.

Pregnancy

There is limited data on the use of parvouiras in pregnant patients. Potential risks should be weighed against benefits.

Breast-feeding

Caution is advised as it is not known whether parvouiras is excreted in human milk.

Storage

Store at room temperature, away from moisture and heat.